Effect of glucocorticoids on von Willebrand factor levels and its correlation with von Willebrand factor gene promoter polymorphism

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 6, 2012, Pages 514-519

  Chopra, Anita ^a   Kumar, Rajive ^b   Kishore, Kamal ^a   Tandon, Nikhil ^c   Yusuf, Tanveer ^b   Kumar, Suman ^a   Mishra, Pravas ^a   Saxena, Renu ^a  

^a Department of Hematology ^*  (India)

^b Laboratory Oncology   (India)

^c INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

cortisol; gene promoter polymorphism; haplotype; von Willebrand factor

Indexed keywords

HYDROCORTISONE; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INDIA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VON WILLEBRAND FACTOR GENE;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CUSHING SYNDROME; DEXAMETHASONE; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GLUCOCORTICOIDS; HAPLOTYPES; HUMANS; HYDROCORTISONE; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; THROMBOPHILIA; VON WILLEBRAND FACTOR;

EID: 84865528957     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283548dfc     Document Type: Article

References (20)

1. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003; 88:5593-5602. (Pubitemid 38033020)
2. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998; 9:647-672. (Pubitemid 28467716)
3. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet 2006; 367:1605-1617. (Pubitemid 43674231)
4. Dal Bo Zanon R, Fornasiero L, Boscaro M, Cappellato G, Fabris F, Girolami A. Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state. Thromb Haemost 1982; 47:116-117. (Pubitemid 12158364)
5. Small M, Lowe GD, Forbes CD. Thomson JA Thromboembolic complications in Cushing's syndrome. Clin Endocrinol 1983; 19:503-511. (Pubitemid 13001512)
6. Patrassi GM, Dal Bo Zanon R, Boscaro M, Martinelli S, Girolami A. Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb Haemost 1985; 54:518-520. (Pubitemid 16255686)
7. Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol 1994; 40:479-484. (Pubitemid 24194645)
8. Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM. Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest 2000; 23:145-150. (Pubitemid 30218782)
9. Boscaro M, Barzon L, Fallo F, Sonino N. Cushing's syndrome. Lancet 2001; 357:783-791. (Pubitemid 32217692)
10. Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MT, Fliers E, et al. Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 2009; 94:2743-2750.
11. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348:1435-1441. (Pubitemid 36407172)
12. Trementino L, Arnaldi G, Appolloni G, Daidone V, Scaroni C, Casonato A, Boscaro M. Coagulopathy in Cushing's syndrome. Neuroendocrinology 2010; 92:55-59.
13. Casonato A, Daidone V, Sartorello F, Albiger N, Romualdi C, Mantero F, et al. Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome. Br J Haematol 2008; 140:230-235. (Pubitemid 350265047)
14. Ruggeri ZM. Von Willebrand factor. Curr Opin Hematol 2003; 10:142-149. (Pubitemid 36207970)
15. Ginsburg D, Wagner DD. Structure, biology and genetics of von Willebrand disease. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE, Anastasi J, editors. Hematology: basic principles and practices, 5th edn. New York: Churchill Livingstone; 2009. pp. 1953-1960.
16. Goodeve AC, Eikenboom JC, Ginsburg D, Hilbert L, Mazurier C, Peake IR, et al., ISTH SSC Subcommittee on von Willebrand factor. A standard nomenclature for von Willebrand factor gene mutations and polymorphisms. On behalf of the ISTH SSC Subcommittee on von Willebrand factor. Thromb Haemost 2001; 85:929-931.
17. Dal Bo Zanon R, Fornasiero L, Boscaro M, Ruffato G, Luzzato G, Fabris F, et al. Clotting changes in Cushing's syndrome: elevated factor VIII activity. Folia Haematol Int Mag Klin Morphol Blutforsch 1983; 110:268-277.
18. Casonato A, Pontara E, Boscaro M, Sonino N, Sartorello F, Ferasin S, Girolami A. Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagul Fibrinolysis 1999; 10:145-151. (Pubitemid 29225577)
19. Keightley AM, Lam YM, Brady JN, Cameron CL, Lillicrap D. Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 1999; 93:4277-4283. (Pubitemid 29279270)
20. Harvey PJ, Keightley AM, Lam YM, Cameron CL, Lillicrap D. A single nucleotide polymorphism at nucleotide: 1793 in the von Willebrand factor (vWF) regulatory region is associated with plasma vWF:Ag levels. Br J Haematol 2000; 109:349-353. (Pubitemid 30350716)